All articles by Juliet Martin
Juliet Martin
Laboratory services poised for the digital revolution
The new COO of Cerba Research, Piet Jamaels, talks about his plans to rewire the lab services firm to optimise for a new world of digital, data and AI in clinical trials management
Trends in global vaccine development: 2023 and beyond
The COVID-19 pandemic stimulated innovation and spotlighted weaknesses in global vaccine development. A panel of experts discusses what we can learn from an unprecedented health event.
How AI, automation, and machine learning are upgrading clinical trials
AI spending in the pharma space is set to grow. Advanced technologies offer opportunities to increase efficiency, quality, and speed at every stage of clinical research.
How automating clinical trial payments can unlock end-to-end efficiencies
Automating clinical trial payment management offers sponsors greater speed, accuracy, and transparency, enabling trials to run more smoothly than ever before
Asia Pacific dominates Phase I clinical trials: a trend analysis
Asia Pacific (APAC) is the fastest growing region for Phase I clinical trials. A new report from GlobalData and Novotech reveals global trends in early-stage clinical research and what makes APAC a competitive and desirable site.
Using analytics and bioassays to de-risk your mRNA LNP drug development programme
The launch of the mRNA Pfizer and Moderna vaccines changed therapeutics overnight, but the technologies and processes involved in mRNA-based applications are still emerging. With no free-to-use template to scale sequences quickly, having a deep understanding of LNP analytics and bioassays becomes crucial to accelerate commercialisation.
Growth opportunities: The clinical trials landscape of Asia-Pacific
Asia-Pacific emerges as one of the most promising and resilient markets for clinical trials.
